New Zealand markets closed

Petros Pharmaceuticals, Inc. (PTPI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6399+0.0055 (+0.87%)
At close: 04:00PM EDT
0.6649 +0.03 (+3.91%)
After hours: 07:46PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.40M
Enterprise value -251.57k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.24
Price/book (mrq)0.36
Enterprise value/revenue -0.04
Enterprise value/EBITDA 0.06

Trading information

Stock price history

Beta (5Y monthly) 2.24
52-week change 3-85.12%
S&P500 52-week change 321.08%
52-week high 35.2400
52-week low 30.6020
50-day moving average 31.2789
200-day moving average 31.7663

Share statistics

Avg vol (3-month) 3985k
Avg vol (10-day) 3495.21k
Shares outstanding 56.88M
Implied shares outstanding 66.88M
Float 86.2M
% held by insiders 111.80%
% held by institutions 11.70%
Shares short (15 Apr 2024) 469.84k
Short ratio (15 Apr 2024) 40.08
Short % of float (15 Apr 2024) 41.27%
Short % of shares outstanding (15 Apr 2024) 41.02%
Shares short (prior month 15 Mar 2024) 488.39k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 301 Dec 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -140.20%
Operating margin (ttm)1,383.29%

Management effectiveness

Return on assets (ttm)-20.32%
Return on equity (ttm)-55.95%

Income statement

Revenue (ttm)5.82M
Revenue per share (ttm)2.68
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -7.48M
Net income avi to common (ttm)-13.81M
Diluted EPS (ttm)-6.3500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.34M
Total cash per share (mrq)1.94
Total debt (mrq)8.28M
Total debt/equity (mrq)66.32%
Current ratio (mrq)1.89
Book value per share (mrq)4.03

Cash flow statement

Operating cash flow (ttm)-7.63M
Levered free cash flow (ttm)-1.39M